Corindus Vascular Robotics (Natick, Massachusetts), a developer of precision vascular robotics, said it has been granted a conditional investigational device exemption (IDE) from the FDA to evaluate the safety and effectiveness of its CorPath 200 system in delivering and manipulating coronary guidewires and stent/balloon systems in percutaneous coronary interventions (PCI). (Medical Device Daily) Read More
